Diploid Genomics, Inc. (DGI) is building a new foundation for precision health—uniting phased diploid genome sequencing with multimodal clinical data and advanced AI to help detect disease earlier, predict risk more accurately, and guide more personalized care. We’re building an integrated, multimodal precision health record that brings together phased diploid genomes, imaging, and clinical data—and a research engine that converts those data into validated diagnostics, biomarkers, and next-generation AI models.